Baxter Q2 2024 sales $3.81B, adj EPS $0.68 beat; raises full-year guidance

BAXTER INTERNATIONAL INC

2024-Q2 EPS reported -$0.54 revenue$7,404,000,000

Sales from continuing ops $3.81B, up 3% reported, 4% constant currency, beating prior guidance.
GAAP diluted EPS from continuing ops ($0.62); adjusted diluted EPS $0.68, above company's guidance.
Full-year sales growth guidance raised to ~3% (reported and CC); adjusted EPS guidance raised to $2.93-$3.01.
Constant currency growth across all segments; CEO cites momentum from strategic transformation and product launches.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.